- Product Code: X1734M
- Size: 100 µg
- Price (USD): $335
References1. Ivanyi, D., et al. (1989). New monoclonal antibodies recognizing epidermal differentiation- associated keratins in formalin-fixed, paraffin-embedded tissue. Keratin 10 expression in carcinoma of the vulva, J Pathol 159, 7-12.
2. Ivanyi, D., et al. (1989). Absence of differentiationrelated expression of keratin 10 in early stages of vulvar squamous carcinoma, Differentiation 42, 124-9.
3. Ivanyi, D., et al. (1990). Keratin subtypes in carcinomas of the uterine cervix: implications for histogenesis and differential diagnosis, Cancer Res 50, 5143-52.
4. Ivanyi, D., et al. (1992). Patterns of expression of feline cytokeratins in healthy epithelia and mammary carcinoma cells, Am J Vet Res 53, 304-14.
5. Vos, J. H., et al. (1992). Immunohistochemistry with keratin monoclonal antibodies in canine tissues: urogenital tract, respiratory tract, (neuro-)endocrine tissues, choroid plexus and spinal cord, J Vet Med 39, 721-40.
6. Ivanyi, D., et al. (1993). Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas, Am J Vet Res 54, 1095-102.
7. Vos, J. H., et al. (1993). The expression of keratins, vimentin, neurofilament proteins, smooth muscle actin, neuron-specific enolase, and synaptophysin in tumors of the specific glands in the canine anal region, Vet Pathol 30, 352-61
8. van Bommel, P. F., et al. (1994). Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix, Cancer 74, 2314-20.